Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Anacor Pharmaceuticals Company Profile (NASDAQ:ANAC)

Consensus Ratings for Anacor Pharmaceuticals (NASDAQ:ANAC) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $24.33 (56.89% upside)

Analysts' Ratings History for Anacor Pharmaceuticals (NASDAQ:ANAC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/17/2014TheStreetUpgradeSell -> BuyViewTweet This Rating  Share This Rating on StockTwits
10/29/2013Canaccord GenuityBoost Price TargetBuy$17.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
10/21/2013Canaccord GenuityBoost Price TargetBuy$13.00 -> $17.00ViewTweet This Rating  Share This Rating on StockTwits
10/18/2013WedbushBoost Price Target$20.00 -> $29.00ViewTweet This Rating  Share This Rating on StockTwits
10/18/2013Deutsche BankBoost Price TargetBuy$11.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
3/22/2013Canaccord GenuityBoost Price TargetBuy$5.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
3/22/2013WedbushBoost Price TargetOutperform$10.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2013Canaccord GenuityLower Price TargetBuy$9.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
12/4/2012CapstoneInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
8/20/2012Canaccord GenuityReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
6/22/2012Canaccord GenuityReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
6/5/2012Canaccord GenuityInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/20/2012 forward)